|
|
Substance Name: Carbutamide [INN:BAN]
RN: 339-43-5
UNII: E3K8P4869P
InChIKey: VDTNNGKXZGSZIP-UHFFFAOYSA-N
Note
- A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277).
Molecular Formula
- C11-H17-N3-O3-S
Molecular Weight
- 271.3393
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Drug / Therapeutic Agent
- Hypoglycemic Agents
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- 1-Butyl-3-sulfanilylurea
- Carbutamide
- Carbutamide [INN:BAN]
MeSH Heading
- Carbutamide
Synonyms
- 1-Butyl-3-sulfanilylurea
- 1-n-Butyl-3-sulfanilylurea
- 4-14-00-02667 (Beilstein Handbook Reference)
- 4-Amino-N-((butylamino)carbonyl)benzenesulfonamide
- Alentin
- Aminophenurobutane
- BRN 2218915
- Bucarban
- Bucrol
- Bukarban
- Burcol
- Butisulfina
- BZ 55
- Ca 1022
- Carbutamid
- Carbutamida
- Carbutamida [INN-Spanish]
- Carbutamide
- Carbutamidum
- Carbutamidum [INN-Latin]
- Diabetin
- Diabetoplex
- Diaboral
- Diabutan
- EINECS 206-424-4
- Emedan
- Glucidoral
- Glucofren
- Glybutamide
- HSDB 5488
- Inbuton
- Invenol
- N'-(4-Aminophenylsulfonyl)-N-butylurea
- N'-(Butylcarbamoyl)sulfanilamide
- N(sup 1)-(Butylcarbamoyl)sulfanilamide
- N(sup 1)-Sulfanilyl-N(sup 2)-butylcarbamide
- N(sup 1)-Sulfanilyl-N(sup 2)-butylurea
- N-(4-Aminobenzenesulfonyl)-N'-butylurea
- N-Butyl-N'-sulfanilylurea
- N-Butylsulfanilylurea
- N-Sulfanilyl N'butyluree
- N-Sulfanilyl N'butyluree [French]
- N-Sulfanilyl-N'-butylurea
- Nadisan
- Nadizan
- Norboral
- NSC 242409
- Oranil
- Oranyl
- Orasulin
- Sulfanilamide, N1-(butylcarbamoyl)-
- Sulfonamide carbutamide
- U 6987
- U-6987
- UNII-E3K8P4869P
Systematic Names
- 1-Butyl-3-sulfanilylurea
- Benzenesulfonamide, 4-amino-N-((butylamino)carbonyl)-
- Carbutamide
- Urea, 1-butyl-3-sulfanilyl-
Registry Numbers
CAS Registry Number
- 339-43-5
FDA UNII
- E3K8P4869P
Other Registry Number
- 1331317-37-3
System Generated Number
- 0000339435
Structure Descriptors
InChI
InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)InChIKey
VDTNNGKXZGSZIP-UHFFFAOYSA-NSmiles
CCCCNC(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 250mg/kg (250mg/kg) | National Technical Information Service. Vol. AD691-490, | |
mouse | LD50 | intravenous | 1920mg/kg (1920mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Diabetes. Vol. 6, Pg. 2, 1957. |
mouse | LD50 | oral | 2800mg/kg (2800mg/kg) | Farmakologiya i Toksikologiya Vol. 25, Pg. 93, 1962. | |
mouse | LD50 | subcutaneous | 2640mg/kg (2640mg/kg) | Diabetes. Vol. 6, Pg. 2, 1957. | |
rat | LD50 | intravenous | 980mg/kg (980mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Diabetes. Vol. 6, Pg. 2, 1957. |
rat | LD50 | oral | 4400mg/kg (4400mg/kg) | French Demande Patent Document. Vol. #2390165, |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 144.5 | deg C | EXP | |
log P (octanol-water) | 1.01 | (none) | EXP | |
Water Solubility | 535 | mg/L | 37 | EXP |
Vapor Pressure | 3.16E-09 | mm Hg | 25 | EST |
Henry's Law Constant | 8.11E-14 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 3.25E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.